EMHA and Gamian

Webinar with Gamian Europe: Migraine and Mental Health Addressing the Challenge On 21st September, 11:00 CET, join us for our webinar: “Migraine and Mental Health: Addressing the Challenge.” Discover how migraines intersect with mental health issues, particularly in women. The webinar is a collaborative initiative between GAMIAN-Europe and the European Migraine and Headache Alliance. During

EMHA and Gamian Read More »

Intranasal ketamine for chronic migraine

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: Research Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care. Methods A retrospective study was conducted at a single tertiary headache center to assess the clinical

Intranasal ketamine for chronic migraine Read More »

EMHA and Prof. Peter Goadsby at BBVA.

At EMHA, we believe that the health and wellbeing of employees is paramount to their success in the workplace. That’s why we were proud to co-host a conference with BBVA that centered on health and emotional management. Our esteemed guest, Professor Peter Goadsby from King’s College London, provided valuable insights on migraines and how to

EMHA and Prof. Peter Goadsby at BBVA. Read More »

Meet the Expert: Messoud Ashina

Messoud Ashina MD PhD DMsc is Professor of Neurology, Danish Headache Center and Department of Neurology, University of Copenhagen, and has been involved into headache research since 1995. He completed his PhD in headache science focusing on tension-type headaches. Since 2006, he has been working on migraine and, in particular, experimental models of migraine. We had the

Meet the Expert: Messoud Ashina Read More »

Access to care: Czech Republic

The Access to care: Czech Republic event. Migraine is one of the most common neurological diseases. Nevertheless, it is underestimated and still underdiagnosed and undertreated throughout Europe. Patients who struggle with this disease are subsequently limited in their personal and professional lives, which has, among other things, a secondary social and economic impact on them.

Access to care: Czech Republic Read More »

Scroll to Top
Close this search box.